The future of biomedical research

JAMA

Volumn 309, Issue 15, 2013, Pages 1589-1590

  Emanuel, Ezekiel J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDGET; ECONOMIC EVALUATION; FUNDING; GOVERNMENT; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; INVESTMENT; MEDICAL RESEARCH; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; SHORT SURVEY; SOCIAL SECURITY; UNITED STATES; ARTICLE; CLINICAL MEDICINE; COST CONTROL; ECONOMICS; FINANCIAL MANAGEMENT; FORECASTING; HEALTH CARE QUALITY; NATIONAL HEALTH ORGANIZATION; SCIENCE;

BIOMEDICAL RESEARCH; BUDGETS; CLINICAL MEDICINE; COST CONTROL; FORECASTING; HEALTH CARE COSTS; NATIONAL INSTITUTES OF HEALTH (U.S.); POLITICS; QUALITY OF HEALTH CARE; RESEARCH SUPPORT AS TOPIC; SCIENCE; UNITED STATES;

MLCS; MLOWN;

EID: 84876328272     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.2096     Document Type: Short Survey

References (10)

1. The NIH Almanac: Section 2: Appropriations. National Institutes of Health website. http://www.nih.gov/about/almanac/appropriations/part2.htm. Accessed February 28, 2013.
2. Office of Management and Budget (OMB). OMB Report to the Congress on the Joint Committee Sequestration for Fiscal Year 2013. White House website. http://www.whitehouse.gov/sites/default/files/omb/assets/legislative-reports/ fy13ombjcsequestrationreport.pdf. March 1, 2013.
3. Newport F. In U.S., 46% Hold Creationist View of Human Origins. Gallup website. http://www.gallup.com/poll/155003/hold-creationist-view-human-origins. aspx. Accessed February 28, 2013.
4. Gauchat G. Politicization of science in the public sphere: a study of public trust in the United States, 1974-2010. Am Sociol Rev. 2012;77:167-187.
5. Medicare. Congressional Budget Office website. http://www.cbo.gov/topics/ health-care/medicare. Accessed February 28, 2013.
6. Medicaid and CHIP. Congressional Budget Office website. http://www.cbo.gov/topics/poverty-and-income-security/medicaid-and-chip. Accessed February 28, 2013.
7. Technological Change and the Growth of Health Care Spending. Congressional Budget Office website. http://www.cbo.gov/publication/41665. January 2008. Accessed February 28, 2013.
8. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [published correction appears in N Engl J Med. 2007;356(3):318]. N Engl J Med. 2006;355(24):2542-2550. (Pubitemid 44917502)
9. Tappenden P, Jones R, Paisley S, Carroll C. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. Health Technol Assess. 2007;11(12):1-128.
10. Goulart B, Ramsey S. A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer. Value Health. 2011;14(6):836-845.